Eduardo Boeri

Dr. Eduardo Boeri

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2009 in Epidemiology and Infection
Verified
Journal Article
Closed access
NLN. E. Lucero
N. E. Lucero
RCR. Corazza
R. Corazza
MAM. N. Almuzara
M. N. Almuzara
ERE. Reynes
E. Reynes
GEG. I. Escobar
G. I. Escobar
SAS. M. Ayala
S. M. Ayala
SUMMARY: The zoonotic risk ofBrucella canishas been considered fairly high for persons who handle breeding dogs in kennels or are exposed to infected animals. Transmission to humans in other circumstances has been thought to be rare. We describe an uncommon outbreak of brucellosis caused byB. caniswhich, to the best of our knowledge, is the first reported in the literature. This outbreak involved six persons (three children and three adults), a bitch and three puppies which had close daily contact with the family. The clinical symptoms of the index case led to an erroneous diagnosis and the infection would have gone undiagnosed if culture had not been positive. This report aims to increase awareness of medical personnel of the need to order screening tests for children, immunodeficient persons or pregnant women presenting with fever of unknown origin, unexplained spleen or liver enlargement or other systemic signs. The emerging zoonotic potential of this disease in urban areas and the need to coordinate canine brucellosis surveillance systems should be evaluated.

13 December 2018 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
PPPablo I. Plaza
Pablo I. Plaza
GBGuillermo Blanco
Guillermo Blanco
MMMaría Julia Madariaga
María Julia Madariaga
EBEduardo Boeri
Eduardo Boeri
MTMaría Luisa Teijeiro
María Luisa Teijeiro
SLSergio A. Lambertucci
Sergio A. Lambertucci

1 June 2010 in Vector-Borne and Zoonotic Diseases
Verified
Journal Article
Closed access
NLNidia E. Lucero
Nidia E. Lucero
PMPatricia L. Maldonado
Patricia L. Maldonado
SKSara Kaufman
Sara Kaufman
GEGabriela I. Escobar
Gabriela I. Escobar
EBEduardo Boeri
Eduardo Boeri
NJNéstor R. Jacob
Néstor R. Jacob
From the blood culture of an HIV-positive patient with a febrile syndrome (CD4 count 385 cells/μL and viral load nondetectable), Brucella canis was isolated. The patient was presumptively infected from his dogs, which tested positive, and showed good outcome after the therapy with doxycycline-ciprofloxacin, and the HIV infection would seem not to have been influenced by brucellosis. To our knowledge, no other case of B. canis in the setting of HIV infection has been reported in the literature, and the emerging zoonotic potential of the disease in urban areas should be considered.

16 February 2018 in Veterinary World
Verified
Journal Article
Open access
EBEduardo Boeri
Eduardo Boeri
MWMaria M. Wanke
Maria M. Wanke
MMMaria J. Madariaga
Maria J. Madariaga
MTMaría Luisa Teijeiro
María Luisa Teijeiro
SESebastian A. Elena
Sebastian A. Elena
MTMarcos David Trangoni
Marcos David Trangoni
This study aimed to compare the sensitivity (S), specificity (Sp), and positive likelihood ratios (LR+) of four polymerase chain reaction (PCR) assays for the detection of Brucella spp. in dog's clinical samples

13 May 2010 in Revista Argentina de Microbiologia
Verified
Journal Article
Closed access
GEG I Escobar
G I Escobar
EBEduardo Boeri
Eduardo Boeri
SAS M Ayala
S M Ayala
NLN E Lucero
N E Lucero
Clinical diagnosis of canine brucellosis is not sensitive enough and a negative blood culture cannot rule out the disease. Indirect methods of serological testing such as agar gel immunodiffusion (AGID), rapid slide agglutination test (RSAT) and indirect enzyme linked immunoassay (IELISA) are preferred for routine diagnosis. Since Brucella canis shares antigenic components with the Brucella ovis and Brucella abortus RB51 strain, it would seem that either strain could be used as antigen. We present data on AGID and IELISA tests using the B. ovis antigen, RSAT and IELISA using the B. canis antigen and IELISA using the B. abortus RB51 antigen. The cut-off values were adjusted by the ROC analysis; the IELISA-B. ovis cut-off value was 23 (%P) and the IELISA-B. abortus RB51, 24 (%P), with 100% sensitivity and 98.8% specificity. RSAT detected 100% of positive cases, while AGID was less sensitive. The sera from dogs treated with antibiotic showed that %P correlated well with the clinical course. Sera from dogs presumptively infected with B. suis were negative in all tests performed with the rough Brucella strains. RSAT is a very sensitive screening test and IELISA-B. canis, B. ovis and B. abortus RB51 could be used as confirmatory tests, since they show good specificity and sensitivity.

1 April 2021 in Revista Argentina de Microbiologia
Verified
Journal Article
Open access
EBEduardo Boeri
Eduardo Boeri
MMMaría Julia Madariaga
María Julia Madariaga
MDMaría Luz Dominguez
María Luz Dominguez
MTMaría Luisa Teijeiro
María Luisa Teijeiro
NFNatalia Mercedes Fernandez
Natalia Mercedes Fernandez
MTMarcos David Trangoni
Marcos David Trangoni
The aim of this study was to estimate the diversity and prevalence of both groups of Brucella canis 1 and 2 with and without deletion respectively in different areas of Argentina. A total of 104 bacterial cultures were typed as B. canis strains using the classical biotyping method. Two PCR assays were performed to confirm that all isolates were B. canis and not Brucella suis. The differentiation between groups 1 and 2 was achieved using another PCR assay and the diversity of B. canis isolates was assessed with four MLVA_16 markers. All strains belonged to Group 2. Bruce 09 marker (MLVA_16 assay) showed the greatest diversity. Only Group 2 of B. canis was identified among the strains evaluated. The markers chosen from the MLVA_16 allowed us to detect genetic diversity among the strains of B. canis studied.